Zobrazeno 1 - 10
of 165
pro vyhledávání: '"E. D. Kreuser"'
Autor:
Thomas Wiegel, Doris Henne-Bruns, E-D Kreuser, W. Baumann, Martina Kron, Marko Kornmann, K-H Link, Ludger Staib
Publikováno v:
British Journal of Cancer
Background: Standard adjuvant chemoradiotherapy of rectal cancer still consists of 5-fluorouracil (5-FU) only. Its cytotoxicity is enhanced by folinic acid (FA) and interferon-α (INFα). In this trial, the effects of FA and IFNα on adjuvant 5-FU ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e87eb30e9803498d1e799a0bea70a9ce
https://doi.org/10.1038/sj.bjc.6605871
https://doi.org/10.1038/sj.bjc.6605871
Autor:
E. D. Kreuser
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 110:1381-1386
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6943826fd64decaecd02246973050523
https://doi.org/10.1055/s-2008-1069016
https://doi.org/10.1055/s-2008-1069016
Autor:
Robert E. Coleman, Mark Verrill, B. Longerey, A. Jones, E. D. Kreuser, M. Brandely, K. Mross, Thierry Delozier, D. Serin
Publikováno v:
British Journal of Cancer
The combination of intravenous (i.v.) vinorelbine and epirubicin is highly active in the treatment of metastatic breast cancer (MBC). In an effort to improve patient convenience, we investigated a regimen alternating i.v. and oral vinorelbine in comb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be7454045f7159acebdac079cf355245
https://doi.org/10.1038/sj.bjc.6602588
https://doi.org/10.1038/sj.bjc.6602588
Autor:
P.M. Black, D. Fritze, R. Pirker, L. Serrone, G. Sotti, P.-U. Tunn, E. Dühmke, T. Muley, J. Kühnel, W. Lichtenegger, C. Neise, F. Fiedler, A. Rost, P. Papaldo, M. Hänel, M. Rauchfuss, M. Bambach, F. Cognetti, W. Queisser, H. Lindemann, M. Schaffer, J.E. Ehlert, M.N. Dworzak, W. Golder, G. Hartung, A. Neuner, G. Schackert, T. Santarius, S. Paepke, Y. Dencausse, M. Kirsch, L. Edler, R.M. Mesters, M. Drees, E.-D. Kreuser, R.-D. Hofheinz, R. Hehlmann, U. Pacetti, M. Krause, A. Hofstetter, R. Malayeri, C. Riedel, P. Dietzler, P.M. Schaffer, P. Drings, G. Jori, J. Sturm, M. Zeuli, C. Thorns, L. Corti, C. Nardoni, H. Lahm, K. Beier, G.V. Kornek, J.R. Fischer, W. Qeißer, U. Schneider, C. Wojatschek, M. Henke, H. Huber, M.H.G. Kubbutat, A. Wein
Publikováno v:
Oncology Research and Treatment. 24:409-414
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f773d81ac9c6497e5b37a500f3eeaaa2
https://doi.org/10.1159/000055120
https://doi.org/10.1159/000055120
Autor:
H. Szelényi, Wolfgang E. Berdel, Eckhard Thiel, N. Haboubi, E. D. Kreuser, H. Lochs, P. Hohenberger
Publikováno v:
Oncology. 58:273-279
Trimetrexate (TMTX) is a new antifolate which avoids competition for cellular uptake with folinic acid (FA). A regimen of sequential TMTX, FA and 5-fluorouracil (5-FU) has shown efficacy in patients with colorectal cancer. Therefore, we treated 34 pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c2a2b52912430e32085509a54c38f29
https://doi.org/10.1159/000012112
https://doi.org/10.1159/000012112
Autor:
E.-D. Kreuser
Publikováno v:
Der Onkologe. 5:39-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e3ad4914eac9766751a1f9a1d9345f4
https://doi.org/10.1007/s007610050322
https://doi.org/10.1007/s007610050322
Publikováno v:
Pharmacy World and Science. 21:184-189
The optimum dose of calcium folinate (leucovorin) as modulator of fluorouracil has not been defined yet. We conducted a randomized trial to compare the pharmacokinetics/pharmacodynamics of two doses of calcium folinate. 16 patients with advanced colo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1d6149b65f13c9ebbaee04fc6e36920
https://doi.org/10.1023/a:1008671129128
https://doi.org/10.1023/a:1008671129128
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 123:420-428
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef0ccebc3f3e7530ccc2d223bd8f114b
https://doi.org/10.1007/s004320050081
https://doi.org/10.1007/s004320050081
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 123:420-428
The effects of prothymosin alpha1 (Pro alpha1) in combination with interleukin-2 (IL-2) on peripheral blood lymphocytes from 50 colorectal tumor patients at different stages were studied with respect to immunocytotoxicity, adhesion to cultured SW620
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84a1afa93f5c7e2c7a890f18c7a0f3bb
https://doi.org/10.1007/bf01372545
https://doi.org/10.1007/bf01372545
Autor:
AC Bloem, M. van Driel, C Schwarzler, HM Lokhorst, W Eisterer, E.-D. Kreuser, Ursula Günthert, Josef Thaler, Reinhard Stauder
Publikováno v:
Blood. 88:3101-3108
CD44 variant isoforms (CD44v) are generated by alternative splicing of the nuclear RNA resulting in the expression of additional protein domains in the extracellular region of the CD44 standard molecule (CD44s). In multiple myeloma (MM), CD44 mediate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::535f162cdaf0db9020029ffa1dbef7d4
https://doi.org/10.1182/blood.v88.8.3101.bloodjournal8883101
https://doi.org/10.1182/blood.v88.8.3101.bloodjournal8883101